[{"address1": "1 Commonwealth Lane, No. 08-22", "city": "Singapore", "zip": "149544", "country": "Singapore", "phone": "65 6250 7738", "website": "https://w2.cytomed.sg", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia and Singapore. Its lead product candidate is CTM-N2D, an expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric antigen receptor, which is in Phase I clinical trials comprising to improve anti-cancer cytotoxicity. The company is also developing iPSC-gdNKT, a pluripotent stem cell-derived gamma delta natural killer T cells platform for cancer treatment; CTM-GDT, a product candidate that consists of expanded allogeneic gamma delta T cells and exploits the potential of the cells to recognize and treat a broad range of cancers; and CTM-MSC, an injectable allogeneic umbilical cord derived mesenchymal stem cells for cartilage injury. It has research collaboration agreement with Sengkang General Hospital to provide CTM-MSC and its conditioned media for in vivo studies and Phase I clinical trial in Singapore. The company also has Business & Research Collaboration Agreement with SunAct Cancer Institute Private Limited to advance use of allogeneic off-the-shelf Gamma Delta T Cells for treatment of solid cancers. CytoMed Therapeutics Limited was incorporated in 2018 and is headquartered in Singapore.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Chee Kong  Choo", "age": 66, "title": "Executive Chairman", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 27316, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jieming  Zeng M.D., Ph.D.", "age": 50, "title": "Chief Scientific & Medical Officer and Director", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 89742, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Yvonne  Goh", "age": 34, "title": "Chief Financial Officer", "yearBorn": 1990, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tien Wee  Luk M.D.", "age": 38, "title": "Chief Clinical Officer", "yearBorn": 1986, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Yoong Ying  Tan", "age": 35, "title": "Chief Corporate Officer", "yearBorn": 1989, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.68, "open": 2.77, "dayLow": 2.5523, "dayHigh": 2.8, "regularMarketPreviousClose": 2.68, "regularMarketOpen": 2.77, "regularMarketDayLow": 2.5523, "regularMarketDayHigh": 2.8, "payoutRatio": 0.0, "forwardPE": -18.666666, "volume": 8327, "regularMarketVolume": 8327, "averageVolume": 217600, "averageVolume10days": 13840, "averageDailyVolume10Day": 13840, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 32312000, "fiftyTwoWeekLow": 1.2, "fiftyTwoWeekHigh": 4.05, "priceToSalesTrailing12Months": 72.17413, "fiftyDayAverage": 2.69036, "twoHundredDayAverage": 2.165825, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 25339316, "profitMargins": 0.0, "floatShares": 3546127, "sharesOutstanding": 11540000, "sharesShort": 190611, "sharesShortPriorMonth": 82175, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0165, "heldPercentInsiders": 0.69271004, "heldPercentInstitutions": 0.0013, "shortRatio": 0.33, "shortPercentOfFloat": 0.1118, "impliedSharesOutstanding": 12054800, "bookValue": 0.881, "priceToBook": 3.1782067, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -3063187, "trailingEps": -0.22, "forwardEps": -0.15, "enterpriseToRevenue": 56.6, "enterpriseToEbitda": -8.12, "52WeekChange": 0.25, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 2.8, "targetHighPrice": 5.0, "targetLowPrice": 5.0, "targetMeanPrice": 5.0, "targetMedianPrice": 5.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 6822869, "totalCashPerShare": 0.591, "ebitda": -3120472, "totalDebt": 428285, "quickRatio": 19.199, "currentRatio": 21.534, "totalRevenue": 447695, "debtToEquity": 4.215, "revenuePerShare": 0.039, "returnOnAssets": -0.17438, "returnOnEquity": -0.26262, "grossProfits": 447856, "freeCashflow": -2590626, "operatingCashflow": -2555008, "revenueGrowth": -0.211, "grossMargins": 1.00036, "ebitdaMargins": 0.0, "operatingMargins": -7.3597302, "financialCurrency": "SGD", "symbol": "GDTC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 4.4776077, "regularMarketPrice": 2.8, "marketState": "REGULAR", "shortName": "CytoMed Therapeutics Limited", "longName": "CytoMed Therapeutics Limited", "corporateActions": [], "regularMarketTime": 1740167522, "exchange": "NCM", "messageBoardId": "finmb_647650276", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1681479000000, "regularMarketChange": 0.119999886, "regularMarketDayRange": "2.5523 - 2.8", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 217600, "fiftyTwoWeekLowChange": 1.5999999, "fiftyTwoWeekLowChangePercent": 1.3333333, "fiftyTwoWeekRange": "1.2 - 4.05", "fiftyTwoWeekHighChange": -1.2500002, "fiftyTwoWeekHighChangePercent": -0.30864203, "fiftyTwoWeekChangePercent": 25.0, "epsTrailingTwelveMonths": -0.22, "epsForward": -0.15, "epsCurrentYear": -0.15, "priceEpsCurrentYear": -18.666666, "fiftyDayAverageChange": 0.10963988, "fiftyDayAverageChangePercent": 0.040752865, "twoHundredDayAverageChange": 0.63417506, "twoHundredDayAverageChangePercent": 0.29280993, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-04-14", "cryptoTradeable": false, "displayName": "CytoMed Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]